{"id":"https://openalex.org/W201153121","doi":null,"title":"MOLECULAR DETERMINANTS OF RESPONSETO ANTIANGIOGENIC THERAPIES INPRECLINICAL MODELS OF HEAD AND NECKSQUAMOUS CELL CARCINOMA","display_name":"MOLECULAR DETERMINANTS OF RESPONSETO ANTIANGIOGENIC THERAPIES INPRECLINICAL MODELS OF HEAD AND NECKSQUAMOUS CELL CARCINOMA","publication_year":2013,"publication_date":"2013-04-30","ids":{"openalex":"https://openalex.org/W201153121","mag":"201153121"},"language":"en","primary_location":{"id":"pmh:oai:d-scholarship.pitt.edu:17327","doi":null,"is_oa":true,"landing_page_url":"https://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","pdf_url":"http://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","source":{"id":"https://openalex.org/S4306402372","display_name":"D-Scholarship@Pitt (University of Pittsburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I170201317","host_organization_name":"University of Pittsburgh","host_organization_lineage":["https://openalex.org/I170201317"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"PeerReviewed"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002725458","display_name":"Rekha Gyanchandani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rekha Gyanchandani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5002725458"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.972000002861023},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7409999966621399},{"id":"https://openalex.org/keywords/anti-vegf-antibody","display_name":"anti-VEGF antibody","score":0.6629999876022339},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.9269999861717224},{"id":"https://openalex.org/keywords/fgf2","display_name":"FGF2","score":0.6729999780654907},{"id":"https://openalex.org/keywords/fgfr3","display_name":"FGFR3","score":0.9700000286102295},{"id":"https://openalex.org/keywords/plcgamma2","display_name":"PLC\u03b32","score":0.8029999732971191},{"id":"https://openalex.org/keywords/fzd4","display_name":"FZD4","score":0.984000027179718},{"id":"https://openalex.org/keywords/cx3cl1","display_name":"fractalkine","score":0.8949999809265137},{"id":"https://openalex.org/keywords/ccl5","display_name":"RANTES","score":1.0},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9929999709129333},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6779999732971191},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7120000123977661},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7867988348007202},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.7441012263298035},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.696068286895752},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6311561465263367},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.6058074831962585},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5825105309486389},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4549432098865509},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.454059362411499},{"id":"https://openalex.org/C171196145","wikidata":"https://www.wikidata.org/wiki/Q4774577","display_name":"Antibody microarray","level":3,"score":0.43728744983673096},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34182941913604736},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.3350856304168701},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3205074071884155},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27784329652786255},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18866270780563354},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1453549861907959},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:d-scholarship.pitt.edu:17327","doi":null,"is_oa":true,"landing_page_url":"https://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","pdf_url":"http://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","source":{"id":"https://openalex.org/S4306402372","display_name":"D-Scholarship@Pitt (University of Pittsburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I170201317","host_organization_name":"University of Pittsburgh","host_organization_lineage":["https://openalex.org/I170201317"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"PeerReviewed"},{"id":"mag:201153121","doi":null,"is_oa":false,"landing_page_url":"http://d-scholarship.pitt.edu/17327/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:d-scholarship.pitt.edu:17327","doi":null,"is_oa":true,"landing_page_url":"https://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","pdf_url":"http://d-scholarship.pitt.edu/17327/1/GyanchandaniR_Dissertation.pdf","source":{"id":"https://openalex.org/S4306402372","display_name":"D-Scholarship@Pitt (University of Pittsburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I170201317","host_organization_name":"University of Pittsburgh","host_organization_lineage":["https://openalex.org/I170201317"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"PeerReviewed"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W201153121.pdf","grobid_xml":"https://content.openalex.org/works/W201153121.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1605318550","https://openalex.org/W1980413003","https://openalex.org/W1988019968","https://openalex.org/W1992112921","https://openalex.org/W2001343980","https://openalex.org/W2001428172","https://openalex.org/W2017322644","https://openalex.org/W2036418044","https://openalex.org/W2047013291","https://openalex.org/W2062275568","https://openalex.org/W2071185061","https://openalex.org/W2095867755","https://openalex.org/W2101918466","https://openalex.org/W2118471405","https://openalex.org/W2139731402","https://openalex.org/W2139877124","https://openalex.org/W2151641152","https://openalex.org/W2161730969"],"related_works":["https://openalex.org/W2334650056","https://openalex.org/W2161315596","https://openalex.org/W2073944569","https://openalex.org/W2094126745","https://openalex.org/W2036496768","https://openalex.org/W3015628445","https://openalex.org/W2739553780","https://openalex.org/W1993786663","https://openalex.org/W1976744990","https://openalex.org/W2908222788"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Head":[2],"and":[3,29,70,110,117,140,164,261,272,288,296],"neck":[4],"squamous":[5],"cell":[6],"carcinoma":[7],"(HNSCC)":[8],"is":[9,40],"the":[10,18,132,168,349],"eighth":[11],"leading":[12],"cancer":[13],"by":[14],"incidence":[15],"worldwide.":[16],"In":[17,101,223],"past":[19],"5":[20],"decades":[21],"there":[22,39,65],"have":[23],"been":[24],"significant":[25],"advances":[26],"in":[27,35,49,57,179,189,211,221,310,324,343],"surgery":[28],"chemoradiotherapy,":[30],"but":[31,219],"very":[32],"little":[33],"improvement":[34],"survival":[36],"rates.":[37],"Hence,":[38],"a":[41,54,60,203,212,224,336],"pressing":[42],"need":[43],"to":[44,73,79,91,113,184,194,217,293,308,326,330,347],"develop":[45],"new":[46],"therapeutic":[47,350],"strategies":[48],"HNSCC.":[50],"Antiangiogenic":[51],"therapy":[52,328],"represents":[53],"promising":[55],"strategy":[56],"at":[58],"least":[59],"subset":[61,213],"of":[62,89,108,121,127,135,155,173,176,181,187,198,214,228,236,277,306,321,352],"patients.":[63],"Currently,":[64],"are":[66],"no":[67],"reliable":[68],"predictive":[69],"resistance":[71,90,112,193,307,318],"biomarkers":[72,120],"identify":[74,87],"those":[75],"patients":[76,200,215],"most":[77],"likely":[78],"benefit.":[80],"Studies":[81],"using":[82,144],"relevant":[83],"preclinical":[84,106,311],"models":[85,107,143],"that":[86,149],"mechanisms":[88,126,305],"antiangiogenic":[92,353],"agents":[93],"will":[94],"help":[95],"meet":[96],"these":[97,341],"challenges.":[98],"Principal":[99],"Findings":[100],"this":[102],"dissertation,":[103],"we":[104,130],"established":[105],"intrinsic":[109,128,317],"acquired":[111,229,331],"anti-VEGF":[114,327],"antibody":[115,145],"bevacizumab":[116,309],"identified":[118,162,301],"potential":[119],"drug":[122],"response.":[123],"To":[124],"characterize":[125],"resistance,":[129,230],"evaluated":[131],"angiogenic":[133],"profile":[134],"HNSCC":[136,199,312],"cells":[137,151],"from":[138],"bevacizumab-sensitive":[139],"-resistant":[141],"tumor":[142],"array.":[146],"We":[147,161],"showed":[148],"resistant":[150,182,291],"expressed":[152],"higher":[153],"levels":[154,210],"proangiogenic":[156],"factors":[157],"including":[158,239],"interleukin-8":[159],"(IL-8).":[160],"PI3K":[163],"IL-1\u03b1":[165],"signaling":[166,315,323],"as":[167],"molecular":[169,304],"basis":[170],"for":[171,339],"overexpression":[172],"IL-8.":[174],"Downregulation":[175],"IL-8":[177,188,209,314],"resulted":[178],"sensitization":[180],"tumors":[183,191,292],"bevacizumab.":[185,195,294],"Overexpression":[186],"sensitive":[190],"conferred":[192],"Serum":[196],"analysis":[197,233],"treated":[201],"with":[202],"bevacizumab-containing":[204],"regime":[205],"indicated":[206],"high":[207],"baseline":[208],"refractory":[216],"treatment":[218],"not":[220],"responders.":[222],"novel":[225],"xenograft":[226],"model":[227],"human-specific":[231],"microarray":[232],"revealed":[234],"upregulation":[235,320],"angiogenesis-related":[237],"genes":[238,268],"fibroblast":[240,244],"growth":[241,245],"factor-2":[242],"(FGF2),":[243],"factor":[246],"receptor-3":[247],"(FGFR3),":[248],"phospholipase":[249],"C":[250],"gamma-2":[251],"(PLCg2),":[252],"frizzled":[253],"receptor-4":[254],"(FZD4),":[255],"chemokine":[256,262],"[C-X3-C":[257],"motif]":[258,264],"ligand-1":[259],"(CX3CL1),":[260],"[C-C":[263],"ligand-5":[265],"(CCL5).":[266],"Upstream":[267],"PLCg2,":[269],"FZD4,":[270],"CX3CL1,":[271],"CCL5":[273],"regulated":[274],"increased":[275,280],"expression":[276],"FGF2":[278],"via":[279],"extracellular":[281],"signal-regulated":[282],"kinase":[283],"(ERK)":[284],"signaling.":[285],"Co-targeting":[286],"VEGF":[287],"FGFR":[289],"sensitized":[290],"Conclusions":[295],"Significance":[297],"Our":[298],"work":[299],"has":[300],"two":[302],"distinct":[303],"models.":[313],"mediated":[316],"while":[319],"FGF":[322],"response":[325],"contributed":[329],"resistance.":[332],"Above":[333],"findings":[334],"provide":[335],"mechanistic":[337],"rationale":[338],"co-targeting":[340],"pathways":[342],"future":[344],"clinical":[345],"trials":[346],"enhance":[348],"efficacy":[351],"therapy.":[354]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}